LEJV SRL
LEJV reported total assets of 34,528 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026).
The score of LEJV shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LEJV's annual accounts
| 2025 | |
|---|---|
| Net result | 24,727 € |
| Equity | 29,727 € |
| Cash | 32,204 € |
| EBITDA | 25,207 € |
| Total assets | 34,528 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
LEJV's financial analysis
- Solvency86.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LEJV
LEJV's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1024.298.125
- VAT number
- BE1024298125
- Peppol
- Registered · 0208:1024298125 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Jun 2025
- Registered office
- 6880 Bertrix
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
LEJV (SRL) has been based in Bertrix since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 24,727 € and equity of 29,727 €; its revenue is not published. Its solvency stands at 86.1%, above the median of its sector (41.5%).
Companies similar to LEJV
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- DEL Pharma Retail sale of pharmaceutical products Mons · balance sheet 36,943 €
- Siga Pharm Retail sale of pharmaceutical products Uccle · balance sheet 46,193 €
- Vanfleteren Pieter Retail sale of pharmaceutical products Antwerp · balance sheet 52,894 €
- Helephar Retail sale of pharmaceutical products Wingene · balance sheet 55,332 €
- Itipharma Ghyselen Retail sale of pharmaceutical products Soignies · balance sheet 61,934 €
- Grace Partner Retail sale of pharmaceutical products Quaregnon · balance sheet 19,066 €
- Camille Loward Retail sale of pharmaceutical products Beersel · balance sheet 18,302 €
Frequently asked questions about LEJV
What is the revenue of LEJV?
LEJV files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LEJV?
In Belgium, the VAT number is the company number prefixed with BE: BE1024298125 for LEJV, if the company is VAT-registered. Its company number (CBE) is 1024.298.125.
Where is the registered office of LEJV?
According to the CBE register, the registered office of LEJV is in 6880 Bertrix.
What is the equity of LEJV?
At the close of the 2025 financial year, the equity of LEJV amounts to 29,727 €, a solvency of 86.1% of total assets.
Who manages LEJV?
The register lists 1 active mandates at LEJV. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LEJV
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →